Analysed ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) News Sources
Here’s What Arcutis’ CEO Said at the Morgan Stanley Healthcare Conference That Made the Stock Jump 11%
17-09-2026
tikr.com
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options
29-09-2026
yahoo.com
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-10-2026
yahoo.com
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
09-10-2026
yahoo.com
What is the current price of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)?
The current price of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) is $28.82.
ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) since the previous trading day is $-0.28.
ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) since the previous trading day is -0.9622%.
What is the most recent average sentiment score for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)?
The most recent average sentiment score for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)?
The most recent sentiment for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) is .
SEC-8K** Filing Available For ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.